iNtRON Biotechnology Inc
KOSDAQ:048530
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
I
|
iNtRON Biotechnology Inc
KOSDAQ:048530
|
KR |
|
A
|
Advanced Holdings Ltd
SGX:BLZ
|
SG |
|
Naver Corp
KRX:035420
|
KR |
|
M
|
Muenchener Rueckversicherungs Gesellschaft in Muenchen AG
XMUN:MUV2
|
DE |
|
Condor Energies Inc
OTC:CNPRF
|
CA |
|
K
|
Kaanapali Land LLC
OTC:KANP
|
US |
|
F
|
Forgent Power Solutions, Inc
F:9FS
|
US |
|
O
|
Octopus Renewables Infrastructure Trust PLC
LSE:ORIT
|
UK |
|
Nozawa Corp
TSE:5237
|
JP |
|
Aurelia Metals Ltd
ASX:AMI
|
AU |
|
LifeVantage Corp
NASDAQ:LFVN
|
US |
|
S
|
Skin Elements Ltd
ASX:SKN
|
AU |
|
Crane NXT Co
F:P8Q
|
US |
|
Atea Pharmaceuticals Inc
NASDAQ:AVIR
|
US |
|
L
|
Lion Asiapac Ltd
SGX:BAZ
|
SG |
|
Element Solutions Inc
NYSE:ESI
|
US |
|
M
|
Meitav Trade Investments Ltd
TASE:MTRD
|
IL |
|
C
|
Cronos Group Inc
XMUN:7CI
|
CA |
Bankruptcy Probability
iNtRON Biotechnology Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
iNtRON Biotechnology Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| KR |
I
|
iNtRON Biotechnology Inc
KOSDAQ:048530
|
86.7B KRW |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
AbbVie Inc
NYSE:ABBV
|
459.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
220.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences, Inc
NASDAQ:GILD
|
183B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
128.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
76B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
75.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
84B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Natera Inc
NASDAQ:NTRA
|
58.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
51B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Revolution Medicines Inc
NASDAQ:RVMD
|
44.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
iNtRON Biotechnology Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, iNtRON Biotechnology Inc has total debt of 5B KRW. This includes both short-term (3B KRW) and long-term (2B KRW) debt.
You can find a full breakdown on its Balance Sheet.